Cabergoline

Intervention

1 paper5 findings

PubChemChEBI

  • 1 lab
  • Animals1

Outcomes

4

T cell exhaustion

downin mice1

1 study
  1. Cabergoline decreases T cell exhaustion in mice.

    “reducing ductal area and proliferation, and reversing T cell exhaustion”

    Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose

    Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women

    Cancer discovery15 Oct 2026

Mammary gland involution

upin mice1

1 study
  1. Cabergoline increases mammary gland involution in mice.

    “cabergoline treatment remodels the mammary gland by potentiating involution”

    Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose

    Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women

    Cancer discovery15 Oct 2026

Time to postpartum mammary cancer onset

upin mice1

1 study
  1. Cabergoline increases time to postpartum mammary cancer onset in mice.

    “delays the onset and reduces the incidence of postpartum mammary cancer in K14-Cre; Brca1F/F, Trp53F/F mice.”

    Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose

    Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women

    Cancer discovery15 Oct 2026

Postpartum mammary cancer incidence

downin mice1

1 study
  1. Cabergoline decreases postpartum mammary cancer incidence in mice.

    “delays the onset and reduces the incidence of postpartum mammary cancer in K14-Cre; Brca1F/F, Trp53F/F mice.”

    Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose

    Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women

    Cancer discovery15 Oct 2026

Associations

1

Postpartum breast cancer incidence

downin humans1−69% lower risk

1 study
  1. Cabergoline is associated with postpartum breast cancer incidence in humans (approximately 69% lower risk).

    “cabergoline treatment was associated with a lower incidence of postpartum breast cancer, with a meta-analysis indicating an approximate 69% reduction in risk.”

    Humanstwo independent retrospective cohorts of European women; pooled associationbreastfemales

    Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women

    Cancer discovery15 Oct 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months